Two documents.
Different questions.

An SDS and a COA are not substitutes.

For BPC-157, GHK-Cu, Semax or another named peptide, begin by identifying the question you need a document to answer. A safety data sheet, often abbreviated SDS, addresses hazard information and precautions for the described material. A certificate of analysis, or COA, reports analytical information on its stated sample or batch basis.

A safety sheet does not establish the measured peptide content of a supplied lot. An analytical report does not replace the handling and emergency information needed by your laboratory. Keep the two review tasks separate even when both documents use the same product name.

Use the section headings as a navigation aid.

OSHA's primary safety-data-sheet brief describes a consistent sixteen-section format. Its sections cover identification, hazards, composition, first aid, handling and storage, exposure controls, physical properties and other technical information, including the revision date. Read OSHA's SDS format guide.

This reference explains document structure. It does not classify an offered peptide, establish our compliance or decide which requirements apply to a particular destination. Your responsible laboratory reviewer should assess the applicable safety information for the actual material and work involved.

Keep a separate check for each record.

Neither document should gain a broader scope simply because it has a professional heading. Read the stated material, method or document purpose before summarising it in your purchasing file.

Check the complete peptide name.

Keep the full accepted specification beside the document identifier. For GHK-Cu, preserve the copper-complex identity. For TB-500, request the sequence or material identity behind the name. For Semax or Selank, distinguish a material enquiry from a particular supplied presentation.

If a blend is proposed, request the complete component specification and ask which material the safety information describes. A safety sheet for one ingredient does not automatically describe the finished mixture. A report on one sample does not establish every component of a kit.

Use the bulk order specification guide to prepare those identity and presentation fields. Do not resolve an abbreviation from an unrelated supplier's document.

Keep sample scope and batch scope visible.

For the COA review, request the relevant sample reference, offered lot connection, methods, results and units. The COA checklist provides the wider field review. The batch traceability guide connects those references to the proposed order and delivery.

An SDS revision and a batch report revision are different identifiers. Keep both versions in your file and ask for clarification when product names or forms differ. Do not overwrite a discrepancy merely to make the documents appear consistent.

A presentation change needs a scope check.

For vials or a defined pen-style kit, list the supplied components and ask which documents apply to each relevant material. Use the format comparison to describe the presentation clearly. Branding artwork is a separate record from either a safety sheet or analytical report.

For an OEM project, confirm how the product identifier on approved artwork maps to the accepted material and document references. A new brand name should not obscure the identity your laboratory reviewed.

Name the records and the review purpose.

Send the named peptides, full required specification, quantities by variant, preferred vial or kit format and destination in the USA, Canada or Australia. Ask which current safety information and sample- or lot-matched analytical records are available for the proposed material.

Record any missing document or unresolved scope as an open question. Document requests do not establish that all records exist, that a batch has passed your criteria or that current local stock is available; ask for those confirmations separately.

Browse the wholesale catalogue, contact the supply team or email sales@wholesalelabpeptides.com.